Insight Pharmaceuticals voluntarily recalls one lot of Nostrilla
LANGHORNE, Pa. — Insight Pharmaceuticals is voluntarily recalling one lot of a nasal decongestant due to the possibility of bacterial contamination, the company said.
Insight said it would recall lot number 11G075, UPC code 6373673005, of Nostrilla nasal spray to the consumer level because of possible contamination with Burkholderia cepacia bacteria. The lot, which contains 34,092 bottles, was distributed nationwide to retail outlets.
“It is our commitment to our customers to provide them with products they can rely on as safe and effective for their [Food and Drug Administration]-approved uses,” Insight CEO Gary Downing said. “Through our standard testing procedures and protocols, we discovered the potential presence of a bacterial contaminant in one lot of Nostrilla and reported it to the FDA. Consumer safety is our No. 1 priority, and we’ll take all necessary action to ensure Nostrilla, as well as all of our products, comply with FDA regulations and requirements."
Burkholderia cepacia can cause serious infections in people with compromised immune systems or chronic lung conditions, though the possibility of infection is remote in healthy people, the drug maker said, and no illnesses have been reported to date in connection with the recalled lot.
Seventh Generation kicks off Nature Makes Perfect Scents sweepstakes
NEW YORK — Green laundry brand Seventh Generation has launched a contest whereby entrants can win a trip for two to France, Italy or Vermont.
The Nature Makes Perfect Scents sweepstakes underscores the source of the scents featured in Seventh Generation’s cleaning products, particularly, its Natural Dish Liquid products:
Seventh Generation uses French lavender used in its lavender and floral mint scent dish product;
Italian lemons and clementines are used in its fresh citrus and ginger, lemongrass and clementine zest scent dish products; and
Free and clear dish liquid scent is sourced from Vermont.
"All of the ingredients used to create our scents come from fields, not factories, honoring their origins and the careful hands that cultivated them," according to the company’s website.
The sweepstakes kicked off Sept. 30 and will end Dec. 31 and winner will be announced on Jan. 2, 2012. For official rules and more information, click here.
NACDS highlights value of community pharmacy in Los Angeles Times letter to the editor
ALEXANDRIA, Va. — The National Association of Chain Drug Stores has engaged its Rapid Response Program, issuing a letter to the editor to the Los Angeles Times to highlight the importance of maintaining prescription medication access to prevent patient health complications and the increased need for costly forms of health care.
Through the Rapid Response Program, NACDS proactively addresses media reports and other communications in the public domain in a way that raises awareness of the value of community pharmacies as the face of neighborhood healthcare.
NACDS responded to an Oct. 18 article in the Los Angeles Times, titled “CDC: Emergency Room Visits Surged in 2009.” The article described preliminary data from the U.S. Centers for Disease Control and Prevention showing that emergency room visits rose nearly 10% to 136 million in 2009.
The text of the letter to the Los Angeles Times from NACDS president and CEO Steve Anderson follows:
If the human costs, financial burdens and inefficiency of skyrocketing emergency room visits are shocking to readers and policy-makers, then here is the really depressing news: It could get even worse.
Although not mentioned specifically in the article, repeated federal and state cuts affecting patients’ access to prescription medications through Medi-Cal stand to leave chronic conditions untreated. While cuts may appear to solve government accounting problems in the short term, they will explode deficits when passed-up prevention leads to greater health complications and costly forms of care, including in the emergency room.
It is more prudent to foster access to medications, and to programs like pharmacist-provided medication therapy management, which empowers patients to understand their medications, take them and do so in a manner that maximizes their effectiveness.
NACDS emphasizes that pharmacy is an effective partner in helping to control healthcare costs, as evidenced by success in such strategies as generic drug utilization. NACDS also emphasizes that neighborhood pharmacies provide unsurpassed value in healthcare delivery and that prescription drug costs should not be viewed in a vacuum.
For example, in North Carolina’s ChecKmeds NC program, face-to-face medication therapy management services for Medicare patients have delivered return-on-investment of $13.55 for every $1 invested, NACDS stated. In addition, according to the New England Journal of Medicine, when New Hampshire imposed prescription limits on its Medicaid population, the state experienced a 35% decrease in its prescription drug costs, but nursing home admissions increased by 60%.
In the private sector, a study conducted by Highmark, a Blue Cross/Blue Shield plan, found that an integrated medical and prescription drug benefit presents optimum savings to employers. Over a four-year period, medical expenses for employers that carved in the pharmacy prescription drug benefit were, on average, 6.2% lower than for those employers that carved out the benefit. The integrated medical and prescription drug benefit helped employers spend an annual average of 15.8% less in outpatient expenses and 7.7% less in emergency room expenses, for approximately $11.44 per member per month in cost avoidance.